
Sign up to save your podcasts
Or


Isan Chen, CEO of MBrace Therapeutics, speaks with Venrock partner Racquel Bracken to discuss his career trajectory leading up to his founding of MBrace. Chen shares the impetus behind his decision to become an oncologist, why he switched from academic medicine to the industry side, lessons learned from years in drug development and more.
By Venrock, a venture capital firm4.8
6262 ratings
Isan Chen, CEO of MBrace Therapeutics, speaks with Venrock partner Racquel Bracken to discuss his career trajectory leading up to his founding of MBrace. Chen shares the impetus behind his decision to become an oncologist, why he switched from academic medicine to the industry side, lessons learned from years in drug development and more.

1,289 Listeners

2,672 Listeners

2,444 Listeners

1,100 Listeners

341 Listeners

324 Listeners

394 Listeners

5,526 Listeners

9,901 Listeners

34 Listeners

505 Listeners

19 Listeners

263 Listeners

517 Listeners

1,354 Listeners